215 related articles for article (PubMed ID: 30720426)
21. Caveolin-1 orchestrates fibroblast growth factor 2 signaling control of angiogenesis in placental artery endothelial cell caveolae.
Feng L; Liao WX; Luo Q; Zhang HH; Wang W; Zheng J; Chen DB
J Cell Physiol; 2012 Jun; 227(6):2480-91. PubMed ID: 21830216
[TBL] [Abstract][Full Text] [Related]
22. Kinetic model for FGF, FGFR, and proteoglycan signal transduction complex assembly.
Ibrahimi OA; Zhang F; Hrstka SC; Mohammadi M; Linhardt RJ
Biochemistry; 2004 Apr; 43(16):4724-30. PubMed ID: 15096041
[TBL] [Abstract][Full Text] [Related]
23. Bone marrow-derived mesenchymal stromal cells promote resistance to tyrosine kinase inhibitors in chronic myeloid leukemia via the IL-7/JAK1/STAT5 pathway.
Zhang X; Tu H; Yang Y; Jiang X; Hu X; Luo Q; Li J
J Biol Chem; 2019 Aug; 294(32):12167-12179. PubMed ID: 31235520
[TBL] [Abstract][Full Text] [Related]
24. FGFR1 signaling stimulates proliferation of human mesenchymal stem cells by inhibiting the cyclin-dependent kinase inhibitors p21(Waf1) and p27(Kip1).
Dombrowski C; Helledie T; Ling L; Grünert M; Canning CA; Jones CM; Hui JH; Nurcombe V; van Wijnen AJ; Cool SM
Stem Cells; 2013 Dec; 31(12):2724-36. PubMed ID: 23939995
[TBL] [Abstract][Full Text] [Related]
25. Compartmentalizing proximal FGFR1 signaling in ovine placental artery endothelial cell caveolae.
Feng L; Zhang HH; Wang W; Zheng J; Chen DB
Biol Reprod; 2012 Aug; 87(2):40. PubMed ID: 22674390
[TBL] [Abstract][Full Text] [Related]
26. Chronic myelogenous leukemia cells remodel the bone marrow niche via exosome-mediated transfer of miR-320.
Gao X; Wan Z; Wei M; Dong Y; Zhao Y; Chen X; Li Z; Qin W; Yang G; Liu L
Theranostics; 2019; 9(19):5642-5656. PubMed ID: 31534508
[No Abstract] [Full Text] [Related]
27. A Cardiac Mitochondrial FGFR1 Mediates the Antithetical Effects of FGF2 Isoforms on Permeability Transition.
Srisakuldee W; Nickel BE; Fandrich RR; Zhang F; Pasumarthi KBS; Kardami E
Cells; 2021 Oct; 10(10):. PubMed ID: 34685716
[TBL] [Abstract][Full Text] [Related]
28. Covalent Targeting of Fibroblast Growth Factor Receptor Inhibits Metastatic Breast Cancer.
Brown WS; Tan L; Smith A; Gray NS; Wendt MK
Mol Cancer Ther; 2016 Sep; 15(9):2096-106. PubMed ID: 27371729
[TBL] [Abstract][Full Text] [Related]
29. The leukemia-associated Mll-Ell oncoprotein induces fibroblast growth factor 2 (Fgf2)-dependent cytokine hypersensitivity in myeloid progenitor cells.
Shah CA; Bei L; Wang H; Platanias LC; Eklund EA
J Biol Chem; 2013 Nov; 288(45):32490-32505. PubMed ID: 24089521
[TBL] [Abstract][Full Text] [Related]
30. Fibroblast growth factor receptors are components of autocrine signaling networks in head and neck squamous cell carcinoma cells.
Marshall ME; Hinz TK; Kono SA; Singleton KR; Bichon B; Ware KE; Marek L; Frederick BA; Raben D; Heasley LE
Clin Cancer Res; 2011 Aug; 17(15):5016-25. PubMed ID: 21673064
[TBL] [Abstract][Full Text] [Related]
31. Different tyrosine autophosphorylation requirements in fibroblast growth factor receptor-1 mediate urokinase-type plasminogen activator induction and mitogenesis.
Dell'Era P; Mohammadi M; Presta M
Mol Biol Cell; 1999 Jan; 10(1):23-33. PubMed ID: 9880324
[TBL] [Abstract][Full Text] [Related]
32. Nuclear translocation of FGFR1 and FGF2 in pancreatic stellate cells facilitates pancreatic cancer cell invasion.
Coleman SJ; Chioni AM; Ghallab M; Anderson RK; Lemoine NR; Kocher HM; Grose RP
EMBO Mol Med; 2014 Apr; 6(4):467-81. PubMed ID: 24503018
[TBL] [Abstract][Full Text] [Related]
33. Nonamplified FGFR1 is a growth driver in malignant pleural mesothelioma.
Marek LA; Hinz TK; von Mässenhausen A; Olszewski KA; Kleczko EK; Boehm D; Weiser-Evans MC; Nemenoff RA; Hoffmann H; Warth A; Gozgit JM; Perner S; Heasley LE
Mol Cancer Res; 2014 Oct; 12(10):1460-9. PubMed ID: 24966347
[TBL] [Abstract][Full Text] [Related]
34. JAK1/2 and BCL2 inhibitors synergize to counteract bone marrow stromal cell-induced protection of AML.
Karjalainen R; Pemovska T; Popa M; Liu M; Javarappa KK; Majumder MM; Yadav B; Tamborero D; Tang J; Bychkov D; Kontro M; Parsons A; Suvela M; Mayoral Safont M; Porkka K; Aittokallio T; Kallioniemi O; McCormack E; Gjertsen BT; Wennerberg K; Knowles J; Heckman CA
Blood; 2017 Aug; 130(6):789-802. PubMed ID: 28619982
[TBL] [Abstract][Full Text] [Related]
35. The cardenolides ouabain and reevesioside A promote FGF2 secretion and subsequent FGFR1 phosphorylation via converged ERK1/2 activation.
Zhao GH; Qiu YQ; Yang CW; Chen IS; Chen CY; Lee SJ
Biochem Pharmacol; 2020 Feb; 172():113741. PubMed ID: 31812679
[TBL] [Abstract][Full Text] [Related]
36. Role of fibroblast growth factor receptors (FGFR) and FGFR like-1 (FGFRL1) in mesenchymal stromal cell differentiation to osteoblasts and adipocytes.
Kähkönen TE; Ivaska KK; Jiang M; Büki KG; Väänänen HK; Härkönen PL
Mol Cell Endocrinol; 2018 Feb; 461():194-204. PubMed ID: 28923346
[TBL] [Abstract][Full Text] [Related]
37. A truncated derivative of FGFR1 kinase cooperates with FLT3 and KIT to transform hematopoietic stem cells in syndromic and de novo AML.
Cai B; Liu Y; Chong Y; Mori SF; Matsunaga A; Zhang H; Fang X; Chang CS; Cowell JK; Hu T
Mol Cancer; 2022 Jul; 21(1):156. PubMed ID: 35906694
[TBL] [Abstract][Full Text] [Related]
38. Honokiol induces apoptosis of lung squamous cell carcinoma by targeting FGF2-FGFR1 autocrine loop.
Cen M; Yao Y; Cui L; Yang G; Lu G; Fang L; Bao Z; Zhou J
Cancer Med; 2018 Dec; 7(12):6205-6218. PubMed ID: 30515999
[TBL] [Abstract][Full Text] [Related]
39. FGFR1 mRNA and protein expression, not gene copy number, predict FGFR TKI sensitivity across all lung cancer histologies.
Wynes MW; Hinz TK; Gao D; Martini M; Marek LA; Ware KE; Edwards MG; Böhm D; Perner S; Helfrich BA; Dziadziuszko R; Jassem J; Wojtylak S; Sejda A; Gozgit JM; Bunn PA; Camidge DR; Tan AC; Hirsch FR; Heasley LE
Clin Cancer Res; 2014 Jun; 20(12):3299-309. PubMed ID: 24771645
[TBL] [Abstract][Full Text] [Related]
40. Signaling pathways implicated in PGF2alpha effects on Fgf2+/+ and Fgf2-/- osteoblasts.
Sabbieti MG; Agas D; Marchetti L; Santoni G; Amantini C; Xiao L; Menghi G; Hurley MM
J Cell Physiol; 2010 Aug; 224(2):465-74. PubMed ID: 20432442
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
